Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/18/15 | 8-K | Current report filing |
|
15 | |
| 05/14/15 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 05/07/15 | 8-K | Current report filing |
|
3 | |
| 05/05/15 | 8-K | Current report filing |
|
41 | |
| 04/10/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
30 |
| 03/26/15 | 8-K | Current report filing |
|
3 | |
| 03/02/15 | 8-K | Current report filing |
|
5 | |
| 02/18/15 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
10 | |
| 02/13/15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 02/11/15 | 8-K | Current report filing |
|
47 |
